相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RHAMM and CD44 peptides-analytic tools and potential drugs
Eva A. Turley et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Variations in the exome of the LNCaP prostate cancer cell line
Lien Spans et al.
PROSTATE (2012)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Nicolas Mottet et al.
EUROPEAN UROLOGY (2011)
Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization
Nobutaka Kobayashi et al.
CANCER RESEARCH (2010)
Tissue microarrays: one size does not fit all
Jeanette E. Eckel-Passow et al.
DIAGNOSTIC PATHOLOGY (2010)
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma
Jochen Greiner et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Bilateral testicular metastasis from prostatic adenocarcinoma mimicking an intertubular pattern of seminoma and expressing Rhamm
Santosh Menon et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2010)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
Bryan P. Toole
CLINICAL CANCER RESEARCH (2009)
Testicular metastases: a poor prognostic factor in patients with advanced prostate cancer
Fernando Korkes et al.
WORLD JOURNAL OF UROLOGY (2009)
RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease
Kilian M. Gust et al.
NEOPLASIA (2009)
Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression
Naoki Itano et al.
CANCER SCIENCE (2008)
Androgen receptor regulates CD168 expression and signaling in prostate cancer
Shi-Lung Lin et al.
CARCINOGENESIS (2008)
Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
Christopher Alan Maxwell et al.
JOURNAL OF CELL SCIENCE (2008)
Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells
Bryan P. Toole et al.
SEMINARS IN CANCER BIOLOGY (2008)
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells
Sara R. Hamilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hyaluronan stimulates transformation of androgen-independent prostate cancer
Shi-Lung Lin et al.
CARCINOGENESIS (2007)
Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia
J Greiner et al.
BLOOD (2005)
Pathologic effects of Neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma - A detailed analysis of radical prostatectomy specimens from a randomized trial
MJ Bullock et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Signaling properties of hyaluronan receptors
EA Turley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Strong stromal hyaluronan expression is associated with PSA recurrence in local prostate cancer
S Aaltomaa et al.
UROLOGIA INTERNATIONALIS (2002)
High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer
P Lipponen et al.
EUROPEAN JOURNAL OF CANCER (2001)
Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer
AV D'Amico et al.
UROLOGY (2000)
分享论文
